JP2022519882A5 - - Google Patents
Info
- Publication number
- JP2022519882A5 JP2022519882A5 JP2021546892A JP2021546892A JP2022519882A5 JP 2022519882 A5 JP2022519882 A5 JP 2022519882A5 JP 2021546892 A JP2021546892 A JP 2021546892A JP 2021546892 A JP2021546892 A JP 2021546892A JP 2022519882 A5 JP2022519882 A5 JP 2022519882A5
- Authority
- JP
- Japan
- Prior art keywords
- adenosine deaminase
- modification
- gsd1a
- base editor
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025017262A JP7906912B2 (ja) | 2019-02-13 | 2025-02-05 | 糖原病1a型を治療するための組成物および方法 |
Applications Claiming Priority (17)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962805271P | 2019-02-13 | 2019-02-13 | |
| US62/805,271 | 2019-02-13 | ||
| US201962852224P | 2019-05-23 | 2019-05-23 | |
| US201962852228P | 2019-05-23 | 2019-05-23 | |
| US62/852,228 | 2019-05-23 | ||
| US62/852,224 | 2019-05-23 | ||
| US201962876354P | 2019-07-19 | 2019-07-19 | |
| US62/876,354 | 2019-07-19 | ||
| US201962912992P | 2019-10-09 | 2019-10-09 | |
| US62/912,992 | 2019-10-09 | ||
| US201962931722P | 2019-11-06 | 2019-11-06 | |
| US62/931,722 | 2019-11-06 | ||
| US201962941569P | 2019-11-27 | 2019-11-27 | |
| US62/941,569 | 2019-11-27 | ||
| US202062966526P | 2020-01-27 | 2020-01-27 | |
| US62/966,526 | 2020-01-27 | ||
| PCT/US2020/018124 WO2020168088A1 (en) | 2019-02-13 | 2020-02-13 | Compositions and methods for treating glycogen storage disease type 1a |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025017262A Division JP7906912B2 (ja) | 2019-02-13 | 2025-02-05 | 糖原病1a型を治療するための組成物および方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022519882A JP2022519882A (ja) | 2022-03-25 |
| JP2022519882A5 true JP2022519882A5 (cg-RX-API-DMAC7.html) | 2023-02-17 |
| JP7631209B2 JP7631209B2 (ja) | 2025-02-18 |
Family
ID=72045644
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021546892A Active JP7631209B2 (ja) | 2019-02-13 | 2020-02-13 | 糖原病1a型を治療するための組成物および方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220127594A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3924478A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7631209B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20210129108A (cg-RX-API-DMAC7.html) |
| CN (2) | CN114026237B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020221355B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3128886A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020168088A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3765615T3 (pl) | 2018-03-14 | 2023-11-13 | Arbor Biotechnologies, Inc. | Nowe enzymy i układy crispr ukierunkowane na dna |
| WO2019217942A1 (en) | 2018-05-11 | 2019-11-14 | Beam Therapeutics Inc. | Methods of substituting pathogenic amino acids using programmable base editor systems |
| WO2019222555A1 (en) | 2018-05-16 | 2019-11-21 | Arbor Biotechnologies, Inc. | Novel crispr-associated systems and components |
| EP3850088A4 (en) | 2018-09-07 | 2023-07-19 | Beam Therapeutics, Inc. | Compositions and methods for improving base editing |
| KR20210055733A (ko) | 2018-09-07 | 2021-05-17 | 빔 테라퓨틱스, 인크. | 핵염기 편집 시스템을 전달하기 위한 조성물 및 방법 |
| JP7646552B2 (ja) | 2019-01-31 | 2025-03-17 | ビーム セラピューティクス インク. | 低減された非標的脱アミノ化を有する核酸塩基エディターおよび核酸塩基エディターの特徴づけのためのアッセイ |
| US12600971B2 (en) | 2019-02-13 | 2026-04-14 | Beam Therapeutics Inc. | Modified immune cells having adenosine deaminase base editors for modifying a nucleobase in a target sequence |
| WO2020168135A1 (en) | 2019-02-13 | 2020-08-20 | Beam Therapeutics Inc. | Compositions and methods for treating alpha-1 antitrypsin deficiency |
| US12594301B2 (en) | 2019-09-27 | 2026-04-07 | Beam Therapeutics Inc. | Compositions and methods for treatment of liquid cancers |
| AU2020397041A1 (en) * | 2019-12-04 | 2022-06-09 | Arbor Biotechnologies, Inc. | Compositions comprising a nuclease and uses thereof |
| EP4103705A4 (en) * | 2020-02-14 | 2024-02-28 | Ohio State Innovation Foundation | Nucleobase editors and methods of use thereof |
| AU2021347359A1 (en) | 2020-09-25 | 2023-05-18 | Beam Therapeutics Inc. | Fratricide resistant modified immune cells and methods of using the same |
| US20230383277A1 (en) * | 2020-10-14 | 2023-11-30 | Beam Therapeutics Inc. | Compositions and methods for treating glycogen storage disease type 1a |
| EP4504947A4 (en) * | 2022-04-07 | 2026-03-25 | Univ Duke | COMPOSITIONS AND METHODS TO PROMOTE LIVER REGENERATION BY GENE EDITING IN METABOLIC LIVER DISEASE |
| CN117568313B (zh) * | 2024-01-15 | 2024-04-26 | 上海贝斯昂科生物科技有限公司 | 基因编辑组合物及其用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017070632A2 (en) * | 2015-10-23 | 2017-04-27 | President And Fellows Of Harvard College | Nucleobase editors and uses thereof |
| US11866727B2 (en) * | 2015-11-06 | 2024-01-09 | Crispr Therapeutics Ag | Materials and methods for treatment of glycogen storage disease type 1A |
| ES3030658T3 (en) * | 2016-03-30 | 2025-07-01 | Intellia Therapeutics Inc | Lipid nanoparticle formulations for crispr/cas components |
| WO2018020323A2 (en) * | 2016-07-25 | 2018-02-01 | Crispr Therapeutics Ag | Materials and methods for treatment of fatty acid disorders |
| WO2018027078A1 (en) * | 2016-08-03 | 2018-02-08 | President And Fellows Of Harard College | Adenosine nucleobase editors and uses thereof |
| KR102709603B1 (ko) * | 2017-02-28 | 2024-09-27 | 보르 바이오파마 인크. | 계통 특이적 단백질의 억제를 위한 조성물 및 방법 |
| CN111328290A (zh) * | 2017-06-26 | 2020-06-23 | 博德研究所 | 用于靶向核酸编辑的基于crispr/cas-腺嘌呤脱氨酶的组合物、系统和方法 |
| US10392616B2 (en) * | 2017-06-30 | 2019-08-27 | Arbor Biotechnologies, Inc. | CRISPR RNA targeting enzymes and systems and uses thereof |
| EP3658573A1 (en) * | 2017-07-28 | 2020-06-03 | President and Fellows of Harvard College | Methods and compositions for evolving base editors using phage-assisted continuous evolution (pace) |
| KR102853088B1 (ko) * | 2018-05-11 | 2025-09-02 | 빔 테라퓨틱스, 인크. | 프로그래밍가능한 염기 편집기 시스템을 이용하여 단일염기다형성을 편집하는 방법 |
| US20230235309A1 (en) * | 2020-02-05 | 2023-07-27 | The Broad Institute, Inc. | Adenine base editors and uses thereof |
-
2020
- 2020-02-13 US US17/430,274 patent/US20220127594A1/en active Pending
- 2020-02-13 JP JP2021546892A patent/JP7631209B2/ja active Active
- 2020-02-13 CN CN202080028267.5A patent/CN114026237B/zh active Active
- 2020-02-13 EP EP20754972.6A patent/EP3924478A4/en active Pending
- 2020-02-13 AU AU2020221355A patent/AU2020221355B2/en active Active
- 2020-02-13 WO PCT/US2020/018124 patent/WO2020168088A1/en not_active Ceased
- 2020-02-13 CA CA3128886A patent/CA3128886A1/en active Pending
- 2020-02-13 KR KR1020217029280A patent/KR20210129108A/ko active Pending
- 2020-02-13 CN CN202510269938.1A patent/CN120138047A/zh active Pending